SCHEMBL31394019

SCHEMBL31394019

Cc1ncc(Br)c(C(=O)O)c1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
KMT2A Q03164 2/20 0.44
P2RX3 P56373 7/20 0.37
ALDH1A1 P00352 3/20 0.37
HTT P42858 1/20 0.37
TTR P02766 1/20 0.36
PDE10A Q9Y233 1/20 0.36
HPGD P15428 2/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
AOX1 Q06278 1/20 0.35
PRNP P04156 1/20 0.35
PPARG P37231 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NR2E3 Q9Y5X4 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
LDHA P00338 1/20 0.34
LDHB P07195 1/20 0.34
TRIM24 O15164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23147036 0.85 KDM4E (0.44) KDM4EKMT2AP2RX3ALDH1A1HTT
SCHEMBL21393836 0.81 KDM4E (0.44) KDM4EKMT2AALDH1A1HTTPDE10A
SCHEMBL29150280 0.78 KDM4E (0.46) KDM4EKMT2AALDH1A1HTTPDE10A
SCHEMBL11562679 0.78 KDM4E (0.65) KDM4EKMT2AP2RX3ALDH1A1PDE10A
SCHEMBL15322103 0.74 KDM4E (0.42) KDM4EKMT2AP2RX3ALDH1A1HTT
SCHEMBL195230 0.74 KDM4E (0.58) KDM4EKMT2AP2RX3ALDH1A1HTT
SCHEMBL29388363 0.74 KDM4E (0.58) KDM4EKMT2AP2RX3ALDH1A1HTT
SCHEMBL14575607 0.74 KDM4E (0.44) KDM4EKMT2AP2RX3ALDH1A1PDE10A
SCHEMBL11625312 0.74 KDM4E (0.42) KDM4EKMT2AP2RX3ALDH1A1PDE10A
SCHEMBL3448876 0.73 KDM4E (0.37) KDM4EKMT2AALDH1A1HTTTTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049746-A1 COMPOSITIONS COMPRISING WERNER SYNDROME HELICASE INHIBITORS AND METHODS OF USING THE SAME EIKON THERAPEUTICS, INC. (US) 2025-03-06 WO disclosed